8TMY | pdb_00008tmy

Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CHM-16


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.07 Å
  • R-Value Free: 
    0.286 (Depositor), 0.283 (DCC) 
  • R-Value Work: 
    0.243 (Depositor), 0.244 (DCC) 
  • R-Value Observed: 
    0.246 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8TMY

This is version 1.2 of the entry. See complete history

Literature

Heterologous betacoronavirus spike immunization in non-human primates elicits antibodies that neutralize both sarbeco- and merbecoviruses.

Dueker, K.Capozzola, T.Feng, Z.Lin, R.N.Hurtado, J.Bangaru, S.Yuan, M.Beutler, N.Garcia, E.He, W.T.Callaghan, S.Avillion, G.Vo, L.Li, X.Torres, J.L.Musharrafieh, R.Song, G.Mishra, N.Sharma, P.Yong, P.Anzanello, F.Kaczmarek Michaels, K.Ben-Akiva, E.Silva, M.Melo, M.Makhdoomi, M.Westfall-Gomez, E.Rinaldi, W.Ferguson, M.Safonova, Y.Crotty, S.Irvine, D.J.Rogers, T.Ward, A.B.Briney, B.Wilson, I.A.Burton, D.R.Andrabi, R.

(2026) Cell Rep 45: 117439-117439

  • DOI: https://doi.org/10.1016/j.celrep.2026.117439
  • Primary Citation Related Structures: 
    8TMY

  • PubMed Abstract: 

    In anticipation of future coronavirus (CoV) pandemics, developing vaccines that elicit broadly neutralizing antibodies (bnAbs) against diverse CoVs is critical. Here, we vaccinated rhesus macaques with the SARS-CoV-2 spike (S)-protein, then boosted with heterologous β-CoV S-proteins to focus responses to common conserved S2 bnAb epitopes. Initial SARS-CoV-2 priming elicited receptor-binding domain (RBD)-focused responses, while MERS-CoV boosting redirected responses toward the S2 region, including the stem-helix bnAb site. Although S2-directed serum cross-neutralization was undetectable and most isolated cross-reactive monoclonal antibodies (mAbs) targeted non-neutralizing epitopes, two S2 stem-helix mAbs were identified from memory B cells. These bnAbs neutralized diverse sarbeco- and merbecoviruses, including MERS-CoV, and conferred robust in vivo protection against SARS-CoV-2 challenge. Structural studies reveal that these macaque bnAbs closely mimic human S2 stem bnAbs induced by infection. These findings provide proof-of-principle for vaccination strategies that elicit broadly protective β-coronavirus responses and highlight non-human primates as a translational model for evaluating S2-targeted immunogens.


  • Organizational Affiliation
    • Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Macromolecule Content 

  • Total Structure Weight: 149.81 kDa 
  • Atom Count: 10,123 
  • Modeled Residue Count: 1,323 
  • Deposited Residue Count: 1,374 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Stem helix peptide of Spike protein S2'A [auth M],
B [auth N],
C [auth S]
25Severe acute respiratory syndrome coronavirus 2Mutation(s): 0 
UniProt
Find proteins for P0DTC2 (Severe acute respiratory syndrome coronavirus 2)
Explore P0DTC2 
Go to UniProtKB:  P0DTC2
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0DTC2
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Neutralizing antibody CHM-16 Heavy ChainD [auth H],
F [auth A],
H [auth C]
221Macaca mulattaMutation(s): 0 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
Neutralizing antibody CHM-16 Light ChainE [auth L],
G [auth B],
I [auth D]
212Macaca mulattaMutation(s): 0 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
FLC

Query on FLC



Download:Ideal Coordinates CCD File
J [auth B]CITRATE ANION
C6 H5 O7
KRKNYBCHXYNGOX-UHFFFAOYSA-K

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.07 Å
  • R-Value Free:  0.286 (Depositor), 0.283 (DCC) 
  • R-Value Work:  0.243 (Depositor), 0.244 (DCC) 
  • R-Value Observed: 0.246 (Depositor) 
Space Group: P 2 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 73.456α = 90
b = 73.677β = 90
c = 330.624γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-2000data reduction
HKL-2000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Bill & Melinda Gates FoundationUnited StatesINV-004923

Revision History  (Full details and data files)

  • Version 1.0: 2024-07-31
    Type: Initial release
  • Version 1.1: 2024-10-16
    Changes: Structure summary
  • Version 1.2: 2026-08-26
    Changes: Database references